FDA & COVID: US Clinical Studies & Market Access Discussion - McDermott Skip to main content

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Overview


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.

Dig Deeper

London / In-person / September 24, 2026

HPE Europe 2026

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

Nashville, TN / In-person / May 20 - 21, 2026

McDermott HealthEx 2026

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Orlando, FL / Speaking Engagements / April 23 – 24, 2026

NAMCP 2026 Spring Managed Care Forum

New York, NY / Speaking Engagements / March 25 – 26, 2026

ACI’s FDA Boot Camp